Propanc Advances PRP Toward First-In-Human Phase 1b Study In Advanced Solid Tumors

Propanc Biopharma (PPCB) commenced preparations for a Phase 1b trial of PRP in up to 40 patients with advanced solid tumors. Avance Clinical will lead protocol finalization and feasibility activities across Australian trial centers.